GDS Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
221,048
+18,086
+9% +$1.26M 0.83% 52
2025
Q4
$13.5M Buy
202,962
+2,510
+1% +$162K 0.84% 46
2025
Q3
$13.5M Buy
200,452
+11,134
+6% +$881K 0.89% 47
2025
Q2
$16.5M Buy
189,318
+14,607
+8% +$1.14M 1.21% 35
2025
Q1
$11.9M Buy
174,711
+14,714
+9% +$1.2M 1.02% 39
2024
Q4
$12.4M Buy
159,997
+24,182
+18% +$1.79M 1.13% 38
2024
Q3
$9.11M Buy
135,815
+81,045
+148% +$6.66M 0.89% 43
2024
Q2
$6.21M Buy
54,770
+16,128
+42% +$2.04M 0.68% 54
2024
Q1
$5.36M Buy
+38,642
New +$4.86M 0.63% 55

Other funds holding DXCM

GDS Wealth Management's DXCM Position: Q1 2026 in Review

GDS Wealth Management increased its DexCom (DXCM) stake by 8.9% in Q1 2026, buying an estimated $1.26M and bringing the position to 221,048 shares worth $13.9M. The position accounts for 0.83% of the portfolio, ranked #52.

GDS Wealth Management first reported a position in DXCM in Q1 2024 and has held it in 9 quarters since. The position peaked at $16.5M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • GDS Wealth Management held 221,048 shares of DexCom worth $13.9M as of Q1 2026.
  • GDS Wealth Management bought 18,086 DexCom shares in Q1 2026, an estimated $1.26M.
  • DexCom made up 0.83% of GDS Wealth Management's portfolio in Q1 2026, its #52 holding.
  • GDS Wealth Management first reported a position in DexCom in Q1 2024 and has held it in 9 quarters since.
  • GDS Wealth Management's DexCom position peaked at $16.5M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on GDS Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.